P05.04 Phase 2 open-label study of maintenance treatment with ibrutinib following first line methotrexate-based immuno-chemotherapy in elderly patients with primary CNS lymphoma (PCNSL)

BACKGROUND: Patients older than 60 years account for up to 70% of all PCNSL cases. Elderly PCNSL patients have median overall survival (OS) under 2 years and progression free survival (PFS) ranging between 6–16 months. Older patients have multiple comorbidities associated with low tolerability to hi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Bairey, O, Amiel, A, Yust-Katz, S, Gurion, R, Siegal, T
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2019
Fag:
Poster Presentations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796039/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.118
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker